What we are seeing in the market.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Vital Signs · MedTech
A device can wait about two years between its first approval and its second, and the lead piece sets out what stretched the longest waits. This month's deals show what buyers paid for medtech companies, from $240 million to $2.1 billion, and what Stryker's $400 million in CMR Surgical buys it.
27 October 2026
Vital Signs · HealthTechTwo Swedish regions abandoned the same hospital record system after €630m. What worked instead was a nurse with a list and a posted letter.
Vital Signs · HealthTechOracle, Microsoft and Athenahealth folded the AI scribe into the health record. Ontario tested twenty approved AI scribes and every one produced an error.